GoHealth, Inc. (NASDAQ:GOCO) Short Interest Down 8.7% in January

GoHealth, Inc. (NASDAQ:GOCO) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 129,400 shares, a decrease of 8.7% from the December 31st total of 141,700 shares. Approximately 1.6% of the company’s stock are sold short. Based on an average daily trading volume, of 38,900 shares, the days-to-cover ratio is currently 3.3 days.

GoHealth Stock Down 0.8 %

Shares of GOCO traded down $0.13 during midday trading on Monday, hitting $16.18. 10,151 shares of the company’s stock traded hands, compared to its average volume of 61,487. GoHealth has a 1 year low of $7.27 and a 1 year high of $18.20. The firm’s fifty day moving average is $13.43 and its 200-day moving average is $11.42. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.72. The stock has a market capitalization of $370.50 million, a price-to-earnings ratio of -4.62 and a beta of 1.64.

GoHealth (NASDAQ:GOCO) last released its quarterly earnings results on Thursday, November 7th. The company reported ($3.73) EPS for the quarter, missing analysts’ consensus estimates of ($3.19) by ($0.54). GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. The business had revenue of $118.29 million during the quarter, compared to analysts’ expectations of $105.93 million. During the same quarter last year, the business posted ($2.61) earnings per share. As a group, sell-side analysts anticipate that GoHealth will post -5.5 earnings per share for the current year.

Institutional Trading of GoHealth

Several large investors have recently bought and sold shares of GOCO. Barclays PLC raised its holdings in shares of GoHealth by 83.9% in the third quarter. Barclays PLC now owns 9,580 shares of the company’s stock worth $89,000 after buying an additional 4,372 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of GoHealth by 99.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company’s stock valued at $79,000 after acquiring an additional 4,204 shares during the period. Renaissance Technologies LLC raised its stake in GoHealth by 22.0% in the 2nd quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock worth $178,000 after acquiring an additional 3,300 shares during the last quarter. Geode Capital Management LLC lifted its position in GoHealth by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company’s stock worth $973,000 after acquiring an additional 3,205 shares during the period. Finally, Empowered Funds LLC grew its stake in GoHealth by 5.3% during the 4th quarter. Empowered Funds LLC now owns 23,218 shares of the company’s stock valued at $311,000 after purchasing an additional 1,170 shares during the last quarter. Hedge funds and other institutional investors own 24.21% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $13.00 price objective on shares of GoHealth in a research report on Monday, October 21st.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.